Dr Lisa Mary Raven's team will complete a 12-month study of SGLT2 inhibitors in 100 people who have had heart transplants to find out whether complications caused by immunosuppressants can be prevented 👏 Read more: heartfoundation.org.au/Bundles/Our-Re… (5/5)
happy to share our latest #AI #medicalimaging work published in #lancet #digitalhealth . Several key findings to highlight: 1) the #deeplearning CT model can predict #lungcancer prognosis after #immunotherapy , which also performs ro…lnkd.in/eEYC8aRc lnkd.in/eN2R69sQ
Clinical Pearl✨
Important parenteral drugs used in Hypertensive emergencies&its contraindications.🚫
💉Beta blockers- asthma,heart block
💉Ca blockers- severe Aortic stenosis
💉Nitroglycerine-Pericardial tamponade
💉Hydralazine- CAD,RHD
💉ACE inhibitors- angioedema
#MedTwitter
#newscience alert! Developing drugs for viruses that mutate quickly is a huge challenge, but Dr. Ali has identified new #HIV inhibitors that are effective in highly-mutated viruses and are even more effective than some drugs currently in #clinicaltrials 👀 sciencedirect.com/science/articl…
Excellent analysis🙌 of the MD. Nadia Harbeck 'Cycling through inhibitors' abemaciclib and ribociclib improve IDFS in HR+/HER2-EBC.
#breastcancer #ASCO23 #ASCO2023
The Breast Cancer Research Foundation Oncología en Twitts OncoAlert ASCO
Happening now! Hussein Tawbi, MD, PhD Hossein Borghaei, DO and Dr Kandalaft discussing Bi-specifics, Checkpoint inhibitors and vaccines as immunotherapies!
#ASCO23 Fox Chase Cancer Center MD Anderson Cancer Center Ludwig Cancer OncoAlert
Insightful discussion of the role of PARP inhibitors in the current treatment landscape for prostate cancer, 'do molecular testing!' David Olmos David VanderWeele MD PhD Fatima Yaftali Karzai, M.D. Sophia Kamran, MD Tian Zhang, MD, MHS #asco2023 UroToday.com
Dr. John Cush Pts high risk for renal failure - high dose IV cyclophosphamide should be considered!
Lastly SGLT2 inhibitors may help. More data needed in lupus but can be used.
Just need to watch for UTIs, dehydration and ketoacidosis.
🟠 SGLT-2 Inhibitors as Enablers of Chronic Glucocorticoid Therapy JACC Journals #CardioEd #Cardiology #CardioTwitter